Serum sHLA-G: Significant diagnostic biomarker with respect to therapy and immunosuppressive mediators in Head and Neck Squamous Cell Carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum sHLA-G: Significant diagnostic biomarker with respect to therapy and immunosuppressive mediators in Head and Neck Squamous Cell Carcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-02
DOI
10.1038/s41598-020-60811-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune Modulation in HLA-G Expressing Head and Neck Squamous Cell Carcinoma in Relation to Human Papilloma Virus Positivity: A Study From Northeast India
- (2019) Neelanjana Sarmah et al. Frontiers in Oncology
- HLA-G as a new tumor biomarker: detection of soluble isoforms of HLA-G in the serum and saliva of patients with colorectal cancer
- (2019) A. D. Lázaro-Sánchez et al. Clinical & Translational Oncology
- Human leucocyte antigen-G 14-bp InDel polymorphism and oral squamous cell carcinoma risk in Chinese Han population: A case-control study
- (2018) Zengqi Wang et al. International Journal of Immunogenetics
- Overexpression of immunomodulatory mediators in oral precancerous lesions
- (2017) Andréia Souza Gonçalves et al. HUMAN IMMUNOLOGY
- Promising link of HLA-G polymorphism, tobacco consumption and risk of Head and Neck Squamous Cell Carcinoma (HNSCC) in North Indian population
- (2017) Vertica Agnihotri et al. HUMAN IMMUNOLOGY
- Human leukocyte antigen‑G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment (Review)
- (2017) Yanwen Zhang et al. Oncology Letters
- Immunosuppressive mediators of oral squamous cell carcinoma in tumour samples and saliva
- (2015) Andréia Souza Gonçalves et al. HUMAN IMMUNOLOGY
- Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy
- (2015) Aifen Lin et al. MOLECULAR MEDICINE
- HLA-G Expression as a Prognostic Indicator in B-Cell Chronic Lymphocytic Leukemia
- (2014) Mohamed A. Attia et al. ACTA HAEMATOLOGICA
- Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis
- (2014) Jianyong Zheng et al. IMMUNOLOGY LETTERS
- Molecular Pathways: Human Leukocyte Antigen G (HLA-G)
- (2013) G. Curigliano et al. CLINICAL CANCER RESEARCH
- The immunosuppressive molecule HLA-G and its clinical implications
- (2012) Ãlvaro González et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Validation Processes of Protein Biomarkers in Serum—A Cross Platform Comparison
- (2012) Katja Köhler et al. SENSORS
- The clinical implications of antitumor immunity in head and neck cancer
- (2011) Clint T. Allen et al. LARYNGOSCOPE
- Altered HLA Class I and HLA-G Expression Is Associated with IL-10 Expression in Patients with Cervical Cancer
- (2011) Josefa Antonia Rodríguez et al. PATHOBIOLOGY
- Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer
- (2011) M. Cao et al. TISSUE ANTIGENS
- Upregulation of human leukocyte antigen–G expression and its clinical significance in ductal breast cancer
- (2010) Hai-Xiao Chen et al. HUMAN IMMUNOLOGY
- In silico analysis of microRNAS targeting the HLA-G 3′ untranslated region alleles and haplotypes
- (2009) Erick C. Castelli et al. HUMAN IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started